Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia

Drug development, from preclinical to clinical studies, is a lengthy and complex process. There is an increased interest in the Kingdom of Saudi Arabia (KSA) to promote innovation, research and local content including clinical trials (Phase I-IV). Currently, there are over 650 registered clinical tr...

Full description

Saved in:
Bibliographic Details
Main Authors: Abdullah Alsultan (Author), Wael A. Alghamdi (Author), Jahad Alghamdi (Author), Abeer F. Alharbi (Author), Abdullah Aljutayli (Author), Ahmed Albassam (Author), Omar Almazroo (Author), Saeed Alqahtani (Author)
Format: Book
Published: Elsevier, 2020-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f1f28a8e4c3344b688db0ebc2fb274f3
042 |a dc 
100 1 0 |a Abdullah Alsultan  |e author 
700 1 0 |a Wael A. Alghamdi  |e author 
700 1 0 |a Jahad Alghamdi  |e author 
700 1 0 |a Abeer F. Alharbi  |e author 
700 1 0 |a Abdullah Aljutayli  |e author 
700 1 0 |a Ahmed Albassam  |e author 
700 1 0 |a Omar Almazroo  |e author 
700 1 0 |a Saeed Alqahtani  |e author 
245 0 0 |a Clinical pharmacology applications in clinical drug development and clinical care: A focus on Saudi Arabia 
260 |b Elsevier,   |c 2020-10-01T00:00:00Z. 
500 |a 1319-0164 
500 |a 10.1016/j.jsps.2020.08.012 
520 |a Drug development, from preclinical to clinical studies, is a lengthy and complex process. There is an increased interest in the Kingdom of Saudi Arabia (KSA) to promote innovation, research and local content including clinical trials (Phase I-IV). Currently, there are over 650 registered clinical trials in Saudi Arabia, and this number is expected to increase. An important part of drug development and clinical trials is to assure the safe and effective use of drugs. Clinical pharmacology plays a vital role in informed decision making during the drug development stage as it focuses on the effects of drugs in humans. Disciplines such as pharmacokinetics, pharmacodynamics and pharmacogenomics are components of clinical pharmacology. It is a growing discipline with a range of applications in all phases of drug development, including selecting optimal doses for Phase I, II and III studies, evaluating bioequivalence and biosimilar studies and designing clinical studies. Incorporating clinical pharmacology in research as well as in the requirements of regulatory agencies will improve the drug development process and accelerate the pipeline. Clinical pharmacology is also applied in direct patient care with the goal of personalizing treatment. Tools such as therapeutic drug monitoring, pharmacogenomics and model informed precision dosing are used to optimize dosing for patients at an individual level. In KSA, the science of clinical pharmacology is underutilized and we believe it is important to raise awareness and educate the scientific community and healthcare professionals in terms of its applications and potential. In this review paper, we provide an overview on the use and applications of clinical pharmacology in both drug development and clinical care. 
546 |a EN 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
655 7 |a article  |2 local 
786 0 |n Saudi Pharmaceutical Journal, Vol 28, Iss 10, Pp 1217-1227 (2020) 
787 0 |n http://www.sciencedirect.com/science/article/pii/S1319016420301833 
787 0 |n https://doaj.org/toc/1319-0164 
856 4 1 |u https://doaj.org/article/f1f28a8e4c3344b688db0ebc2fb274f3  |z Connect to this object online.